ACLY - ATP citrate lyase Gene
Also Known as ACL; ATPCL; CLATP
Species: Homo sapiens
About ACLY
This gene has 10 transcripts (splice variants) and 282 orthologues. Ubiquitous expression in prostate (RPKM 37.3), kidney (RPKM 29.2) and 25 other tissues.
Summary
ATP Citrate Lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several important biosynthetic pathways, including lipogenesis and cholesterogenesis. In nervous tissue, ATP citrate-lyase may be involved in the biosynthesis of acetylcholine. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Dec 2014]
ACLY Products (5)
| mRNA | Protein | Name |
|---|---|---|
| NM_198830.2 | NP_942127.1 | ATP-citrate synthase isoform 2 |
| NM_001303275.1 | NP_001290204.1 | ATP-citrate synthase isoform 4 |
| XM_005257395.2 | XP_005257452.1 | ATP-citrate synthase isoform X1 |
| NM_001303274.1 | NP_001290203.1 | ATP-citrate synthase isoform 3 |
| NM_001096.3 | NP_001087.2 | ATP-citrate synthase isoform 1 |
Gene Ontology
- Molecular Function
- Biological Process
- Cellular Component
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables ATP citrate synthase activity |
IDA
IDA: Inferred from direct assay
|
1371749 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
23932781 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in acetyl-CoA biosynthetic process |
IDA
IDA: Inferred from direct assay
|
1371749 | GOA |
| involved in citrate metabolic process |
IDA
IDA: Inferred from direct assay
|
1371749 | GOA |
| involved in fatty acid biosynthetic process |
IDA
IDA: Inferred from direct assay
|
10653665 | GOA |
| involved in lipid biosynthetic process |
IDA
IDA: Inferred from direct assay
|
23932781 | GOA |
| involved in oxaloacetate metabolic process |
IDA
IDA: Inferred from direct assay
|
1371749 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in cytosol |
IDA
IDA: Inferred from direct assay
|
9116495 | GOA |
ACLY Protein Structure
ATP-grasp_2: ATP-grasp domain (52 - 207)
CoA_binding: CoA binding domain (495 - 600)
Ligase_CoA: CoA-ligase (660 - 784)
Citrate_synt: Citrate synthase, C-terminal domain (888 - 1085)
- 0
- 200
- 400
- 600
- 800
- 1000
- 1101 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
ATP-citrate synthase |
|
Recombinant ACLY Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P72070 | ACLY Protein, Human (His-SUMO) | P53396 (K4-K265) | ≥ 90%, as determined by reducing SDS-PAGE. |
ACLY Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P80380 | ATP Citrate Lyase Antibody (YA596) | WB, ICC/IF, IHC-P, IP, FC | Human, Mouse |
| HY-P80560 | ATP Citrate Lyase Antibody (YA829) | WB, ICC/IF, FC | Human, Mouse, Monkey |
| HY-P80560A | ATP Citrate Lyase Antibody (YA829)(PBS only) | WB, ICC/IF, FC | Human, Mouse, Monkey |
| HY-P84388 | ATP Citrate Lyase Antibody (YA4085) | WB, IHC-P, ICC/IF, FC, ELISA | Human, Mouse, Rat, Monkey, Rabbit |
| HY-P84388A | ATP Citrate Lyase Antibody (YA4085)(PBS only) | WB, IHC-P, ICC/IF, FC, ELISA | Human, Mouse, Rat, Monkey, Rabbit |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Diabetes Mellitus |
|
|
| Soft Palate Cancer |
|
|
| Diseases | Alias | |
|---|---|---|
| Waldenstroem'S Macroglobulinemia |
Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13001 | Quizartinib | 99.08% | Yes | |
| HY-109539 | Gemtuzumab ozogamicin | Inducer | 98.00% | Unkown |
| HY-B0091 | Adapalene | 99.94% | Yes | |
| HY-14217 | Quizartinib dihydrochloride | 99.81% | Unkown | |
| HY-14277A | Levocabastine hydrochloride | Antagonist | 99.37% | Unkown |
| HY-B0393 | Fudosteine | 98.0% | Unkown | |
| HY-B0491A | Carbazochrome sodium sulfonate | 98.0% | Unkown | |
| HY-B0091R | Adapalene (Standard) | / | Unkown | |
| HY-13001R | Quizartinib (Standard) | / | Unkown | |
| HY-B0091A | Adapalene sodium salt | 99.69% | Yes |
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P2827 | Acetyl-CoA synthetase | 90.00% | Phase 4 | |
| HY-156655A | Olgotrelvir sodium | Inhibitor | 95.0% | Phase 3 |
| HY-156655 | Olgotrelvir | Inhibitor | / | Phase 3 |
| HY-15527 | Emapunil | Inhibitor | 99.94% | Phase 2 |
| HY-106025 | Radequinil | Antagonist | 99.25% | Phase 2 |
| HY-P1454 | Fz7-21 | Antagonist | 99.31% | Phase 1 |
| HY-12010 | BMS-599626 Hydrochloride | Inhibitor | 98.90% | Phase 1 |
| HY-10251 | BMS-599626 | Inhibitor | 98.56% | Phase 1 |
| HY-144289 | BMS-820132 | Activator | 99.75% | Phase 1 |
| HY-16021 | AC-430 | Inhibitor | / | Phase 1 |
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99362 | Ensituximab | Inhibitor | 99.93% | Phase 2 |
| HY-P991512 | SGN-30 | Inducer | 96.503% | Phase 2 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-18657 | TEPP-46 | Activator | 99.93% | Unkown |
| HY-100396 | SQ22536 | Inhibitor | 99.98% | Unkown |
| HY-16990 | Ac-YVAD-cmk | Inhibitor | 99.63% | Unkown |
| HY-W728531 | Ac4ManNAz | Inhibitor | 99.94% | Unkown |
| HY-16450 | SB 204990 | Inhibitor | 99.75% | Unkown |
| HY-118297 | Ac4ManNAz (80% α isomer) | 99.74% | Unkown | |
| HY-110288 | 3FAx-Neu5Ac | 99.88% | Unkown | |
| HY-113402 | Gamma-glutamylcysteine | 98.53% | Unkown | |
| HY-P1001 | Ac-DEVD-CHO | Inhibitor | 99.76% | Unkown |
| HY-133870 | Itaconate-alkyne | 98.01% | Unkown | |
| HY-P1098 | Ac2-26 | Inhibitor | 99.43% | Unkown |
| HY-141128 | Ac4GalNAz | 99.99% | Unkown | |
| HY-Y1977 | 100 mM Pro-Ac, 20 mM Arg, pH 5.0 buffer | 99.29% | Unkown | |
| HY-104032 | Ac-CoA Synthase-IN-1 | Inhibitor | 99.70% | Unkown |
| HY-125798 | 2,3-Dehydro-2-deoxy-N-acetylneuraminic acid | Inhibitor | ≥99.0% | Unkown |
| HY-124500 | AC-4-130 | 99.93% | Unkown | |
| HY-127111 | NDI-091143 | Inhibitor | 99.90% | Unkown |
| HY-112942A | CMP-Sialic acid sodium salt | 92.51% | Unkown | |
| HY-122214 | AC-73 | Inducer | 99.91% | Unkown |
| HY-15967 | PS48 | Activator | 99.71% | Unkown |
| HY-101801 | Ac-Gly-BoroPro | 98.0% | Unkown | |
| HY-107636 | DC_AC50 | Inducer | 99.98% | Unkown |
| HY-124004 | Acetyl-6-formylpterin | 95.0% | Unkown | |
| HY-100958 | 4-DAMP | 99.96% | Unkown | |
| HY-P1003 | Ac-DEVD-AMC | 99.18% | Unkown | |
| HY-P1005 | Ac-DEVD-AFC | 98.89% | Unkown | |
| HY-145765 | JQAD1 | 98.24% | Unkown | |
| HY-W039953 | Ac4GlcNAz | 99.60% | Unkown | |
| HY-160429 | PSAR18-COOH | 99.50% | Unkown | |
| HY-P10149 | Ac-IEPD-CHO | Inhibitor | 99.91% | Unkown |
| HY-111675 | Ac-FLTD-CMK | Inhibitor | 99.18% | Unkown |
| HY-P1098A | Ac2-26 TFA | Inhibitor | 98.09% | Unkown |
| HY-101279 | ST034307 | Inhibitor | 99.11% | Unkown |
| HY-P1393 | AC 187 | 98.86% | Unkown | |
| HY-N1437 | Hydroxycitric acid | 99.95% | Unkown | |
| HY-W087027 | Maleimide-NOTA | 99.69% | Unkown | |
| HY-138159 | Boc-Lys(Ac)-AMC | 98.59% | Unkown | |
| HY-149302 | MC4033 | 98.26% | Unkown | |
| HY-P3236 | N-Acetyl-Ile-Glu-Pro-Asp-p-nitroanilide | Substrate | 99.77% | Unkown |
| HY-32264 | X-Neu5Ac sodium | Inhibitor | 99.98% | Unkown |
| HY-P1393A | AC 187 TFA | 99.51% | Unkown | |
| HY-W014130 | N-Acetyl-L-arginine | 99.97% | Unkown | |
| HY-122051 | AC1903 | Inhibitor | 99.69% | Unkown |
| HY-123630 | Allura Red AC | 99.00% | Unkown | |
| HY-160109 | Ac5GalNTGc | 98.54% | Unkown | |
| HY-N2609 | 7,4'-Dihydroxyflavone | Inhibitor | 99.64% | Unkown |
| HY-P10069 | Ac-pSar12-OH | 99.52% | Unkown | |
| HY-P1092 | Ac-IEPD-AFC | 99.97% | Unkown | |
| HY-103430A | SKF-83566 | Antagonist | 99.86% | Unkown |
| HY-123051 | Ac-WLA-AMC | 99.48% | Unkown | |
| HY-145237 | BM213 | 99.81% | Unkown | |
| HY-D1705 | Ac-ANW-AMC | 98.88% | Unkown | |
| HY-W1126504 | ETN029 | Ligand | 99.91% | Unkown |
| HY-120019 | Ac-YVAD-CHO | Inhibitor | 98.99% | Unkown |
| HY-P1006 | Ac-DEVD-pNA | Substrate | 99.70% | Unkown |
| HY-123052 | Ac-PAL-AMC | 99.90% | Unkown | |
| HY-403538 | iZMYND8-34 | Inhibitor | 98.89% | Unkown |
| HY-79490 | Ac-Exatecan | Inhibitor | 99.02% | Unkown |
| HY-113402A | Gamma-glutamylcysteine TFA | 96.68% | Unkown | |
| HY-136727 | Ac-LEVD-CHO | Inhibitor | 99.08% | Unkown |
| HY-175606 | EVT0185 | Inhibitor | 99.39% | Unkown |
| HY-P1093 | Ac-LEHD-AFC | 99.95% | Unkown | |
| HY-141866 | Acid Ceramidase-IN-1 | Inhibitor | 99.36% | Unkown |
| HY-P4846 | Ac-Pro-Gly-Pro-OH | 99.49% | Unkown | |
| HY-100738 | Ubiquitin Isopeptidase Inhibitor I, G5 | Inducer | 98.0% | Unkown |
| HY-154818 | Bovine Serum Albumin, Acetylated | / | Unkown | |
| HY-P0034A | Ac-DEVD-CMK TFA | Inhibitor | 98.09% | Unkown |
| HY-P2377 | Ac-YVAD-AFC | 99.90% | Unkown | |
| HY-66007 | Ac-β-Ala-OH | 98.0% | Unkown | |
| HY-P1368 | Stressin I | Agonist | 98.85% | Unkown |
| HY-W008986 | Fmoc-Lys(Ac)-OH | 99.79% | Unkown | |
| HY-122822 | GSK699 | 98.80% | Unkown | |
| HY-136744 | Caspase-9 Inhibitor III | Inhibitor | 98.78% | Unkown |
| HY-NP159 | House Dust Mite Extract, from D.farinae | Activator | / | Unkown |
| HY-14350 | AC-55541 | Agonist | 99.40% | Unkown |
| HY-122025 | AC-262536 | Agonist | 99.49% | Unkown |
| HY-174216 | PZL-A | Activator | 99.72% | Unkown |
| HY-D2869 | Ac-H-FluNox | 99.88% | Unkown | |
| HY-P2016 | Ac-Nle-Pro-Nle-Asp-AMC | 99.36% | Unkown | |
| HY-P5247 | Palmitoyl tetrapeptide-20 | Activator | 99.21% | Unkown |
| HY-W004066 | Ac-Ala-OH | 98.0% | Unkown | |
| HY-151852 | 9AzNue5Ac | ≥95.0% | Unkown | |
| HY-P1169 | Ac-IETD-AFC | 99.28% | Unkown | |
| HY-P2617A | Ac-WEHD-AFC TFA | 98.84% | Unkown | |
| HY-147286 | Ac-Lys-Val-Cit-PABC-MMAE | 99.94% | Unkown | |
| HY-P2091 | Ac-YVAD-pNA | 98.01% | Unkown | |
| HY-103195 | NKY80 | Inhibitor | 99.76% | Unkown |
| HY-124680 | AC-263093 free base | Inhibitor | 99.66% | Unkown |
| HY-14425 | Peturadol | Inhibitor | 99.91% | Unkown |
| HY-147368 | PKM2 activator 2 | Activator | 99.38% | Unkown |
| HY-158123 | PSMA binder-1 | 98.88% | Unkown | |
| HY-160821A | N-Acetylmannosamine 6-phosphate sodium salt | 95.0% | Unkown | |
| HY-163828 | PPA24 | 98.09% | Unkown | |
| HY-P10201A | Ac-GpYLPQTV-NH2 acetate | Inhibitor | 99.00% | Unkown |
| HY-P10939A | Ac-DMLD-CMK TFA | Inhibitor | 98.44% | Unkown |
| HY-P1098B | Ac2-26 ammonium | Degrader | 97.45% | Unkown |
| HY-P4417A | Ac-IEPD-AMC TFA | 99.33% | Unkown | |
| HY-104004 | Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH | 99.12% | Unkown | |
| HY-135070 | Ac-RLR-AMC | 98.91% | Unkown | |
| HY-14351 | AC-264613 | Agonist | 98.3% | Unkown |
| HY-D1652 | Ac-LEHD-AMC | Chemical | 98.96% | Unkown |
| HY-W338584 | Hydroxycitric acid tripotassium | 98.0% | Unkown | |
| HY-P10639 | C5aR2 agonist P32 | Agonist | 99.17% | Unkown |
| HY-W102456 | H-Phe(4-Ac)-OH | 99.19% | Unkown | |
| HY-148859 | AA-T3A-C12 | 99.76% | Unkown | |
| HY-108532 | AC-261066 | Agonist | 99.27% | Unkown |
| HY-N2098 | Obtusifolin | Inhibitor | 99.91% | Unkown |
| HY-P1368A | Stressin I TFA | Agonist | 98.63% | Unkown |
| HY-W016749 | N-Acetyl-DL-aspartic acid | 99.93% | Unkown | |
| HY-137683A | Guanosine 5'-O-2-thiodiphosphate trisodium | Inhibitor | 97.11% | Unkown |
| HY-111554 | AcLys-PABC-VC-Aur0101 | Inhibitor | 97.17% | Unkown |
| HY-113963 | Ac-IETD-CHO | Inhibitor | 98.59% | Unkown |
| HY-138586 | DMT-dC(ac) Phosphoramidite | Activator | 99.76% | Unkown |
| HY-N1510 | Kaempferol 3-O-gentiobioside | Inhibitor | 99.88% | Unkown |
| HY-P0034 | Ac-DEVD-CMK | Inhibitor | 98.81% | Unkown |
| HY-P10925A | (Z)-Zolucatetide | Inhibitor | 98.19% | Unkown |
| HY-P2462 | Ac-Arg-Gly-Lys(Ac)-AMC | 99.86% | Unkown | |
| HY-P4449A | Ac-VRPR-AMC TFA | 99.60% | Unkown | |
| HY-151819 | N3Ac-OPhOMe | 95.96% | Unkown | |
| HY-144549 | LXR agonist 1 | Agonist | 99.95% | Unkown |
| HY-146356 | Adenylyl cyclase type 2 agonist-1 | Agonist | 99.37% | Unkown |
| HY-P10235 | Cyclic AC253 | Antagonist | 99.83% | Unkown |
| HY-P4547 | Ac-Trp-Glu-His-Asp-AMC | 99.81% | Unkown | |
| HY-P4764 | Ac-(d-Arg)-CEH-(d-Phe)-RWC-NH2 | Agonist | 99.96% | Unkown |
| HY-W145561 | Neu5Acα(2-3)Galβ MP glycoside | 99.84% | Unkown | |
| HY-21648 | 2'-OMe-Ac-C Phosphoramidite | 98.0% | Unkown | |
| HY-120833 | Ac-Ile-Glu-Thr-Asp-pNA | 98.17% | Unkown | |
| HY-108312A | Ac-VEID-CHO TFA | Inhibitor | 99.77% | Unkown |
| HY-108526 | AC-55649 | Agonist | 99.70% | Unkown |
| HY-116530 | 9-Cyclopentyladenine monomethanesulfonate | Inhibitor | 99.95% | Unkown |
| HY-116874 | SKF 83822 | Agonist | 98.01% | Unkown |
| HY-137918 | TGF-βRI inhibitor 3 | Inhibitor | 99.16% | Unkown |
| HY-151516 | microRNA-21-IN-2 | Inhibitor | 99.45% | Unkown |
| HY-161024 | AC1Q3QWB | Inhibitor | 99.39% | Unkown |
| HY-E70445 | Chondroitinase AC II | / | Unkown | |
| HY-P1454A | Fz7-21 TFA | Antagonist | 98.12% | Unkown |
| HY-P2717 | Ac-YVAD-AMC | Inhibitor | 99.64% | Unkown |
| HY-P3455 | Ac-SVVVRT-NH2 | Modulator | 98.68% | Unkown |
| HY-P4417 | Ac-IEPD-AMC | 99.34% | Unkown | |
| HY-P5378A | Ac-KQKLR-AMC TFA | / | Unkown | |
| HY-P5983 | Ac-VEID-AFC | 99.28% | Unkown | |
| HY-W011982 | Ac-DL-Trp-OH | 98.96% | Unkown | |
| HY-113402R | Gamma-glutamylcysteine (Standard) | 98.14% | Unkown | |
| HY-P10336 | Serpinin | Agonist | 98.74% | Unkown |
| HY-132197 | CBP/p300-IN-12 | Inhibitor | 99.72% | Unkown |
| HY-100336 | AC260584 | Agonist | 99.48% | Unkown |
| HY-103688 | N-Ac-γ-Calicheamicin-AcBut-NHS ester | 95.62% | Unkown | |
| HY-147117 | NHS-SS-Ac | 95.0% | Unkown | |
| HY-148041 | ATPase-IN-2 | Inhibitor | 98.0% | Unkown |
| HY-148324 | PKM2 activator 5 | Activator | 96.03% | Unkown |
| HY-174968B | 4-Arm-PEG10000-AC | 95.0% | Unkown | |
| HY-P11212 | Ac-RHKK(Ac)-AMC | 99.68% | Unkown | |
| HY-P3115 | Ac-LEVD-AFC | 98.11% | Unkown | |
| HY-P3434A | Ac-FEID-CMK TFA | Inhibitor | 97.06% | Unkown |
| HY-P3662 | Ac-[Nle4,D-Phe7]-α-MSH (4-10)-NH2 | Activator | 99.44% | Unkown |
| HY-158783 | SACLAC | 99.70% | Unkown | |
| HY-168992A | UNC6535 TFA | / | Unkown | |
| HY-18700 | BRD73954 | Inhibitor | 99.13% | Unkown |
| HY-45491 | Dmt-2'-f-dc(ac) amidite | 99.01% | Unkown | |
| HY-W077279 | 5'-O-DMT-N4-Ac-dC | 97.16% | Unkown | |
| HY-W101367 | Ac-Cys(Bzl)-OH | 99.72% | Unkown | |
| HY-132934 | Ac32Az19 | Inhibitor | 98.12% | Unkown |
| HY-P6825 | PNT2001 | Ligand | 98.72% | Unkown |
| HY-110157 | AC-186 | Agonist | 99.61% | Unkown |
| HY-117851 | AC-265347 | Agonist | 99.97% | Unkown |
| HY-150246 | RNA splicing modulator 1 | Modulator | 99.53% | Unkown |
| HY-18234C | Leupeptin Ac-LL hydrochloride | Inhibitor | 95.0% | Unkown |
| HY-P0266B | N-Acetyl-Ser-dAsp-Lys-Pro acetate | 99.88% | Unkown | |
| HY-P0280 | MUC5AC motif peptide | 98.97% | Unkown | |
| HY-P10143 | MMP-2/MMP-9 Substrate | Substrate | 98.48% | Unkown |
| HY-P10816 | PACE4 Inhibitory peptide C23 | 99.40% | Unkown | |
| HY-P11213 | Ac-RYQK(Ac)-AMC | 99.95% | Unkown | |
| HY-P11287A | DOTA-Pep-1L TFA | Ligand | 98.60% | Unkown |
| HY-P2285 | AC 253 | Antagonist | 98.54% | Unkown |
| HY-P2615A | Ac-VDVAD-AFC TFA | 98.26% | Unkown | |
| HY-P2939 | Chondroitinase AC | Inducer | / | Unkown |
| HY-P3318 | Boc-Phe-Leu-Phe-Leu-Phe | Antagonist | 98.10% | Unkown |
| HY-W012713 | Ac-D-Ala-OH | 98.0% | Unkown | |
| HY-179591 | BGT-002 | 99.35% | Unkown | |
| HY-153094 | BDM-2 | Inhibitor | 99.09% | Unkown |
| HY-124609 | CAD031 | 99.39% | Unkown | |
| HY-13856 | (R)-PS210 | Inhibitor | 98.09% | Unkown |
| HY-140343 | Ac4GalNAl | 99.78% | Unkown | |
| HY-145830 | AC1-IN-1 | Inhibitor | 99.32% | Unkown |
| HY-158118 | Lys(CO-C3-p-I-Ph)-OMe | 97.19% | Unkown | |
| HY-170534 | Ac-EEVC-OH | 99.11% | Unkown | |
| HY-173374 | DOTAGA-FAP-2286-ALB | Inhibitor | 99.29% | Unkown |
| HY-P10781 | PSMA-D5 | Modulator | 98.61% | Unkown |
| HY-P1118 | Ac9-25 | 98.14% | Unkown | |
| HY-P1448 | Ac-Leu-Arg-AMC | 98.17% | Unkown | |
| HY-P2065 | Ac-VEID-AMC | 98.60% | Unkown | |
| HY-P3155 | Ac-hMCH(6-16)-NH2 | Agonist | 99.94% | Unkown |
| HY-P4665 | Ac-c[Cys-Glu-His-d-Phe-Arg-Trp-d-Cys]-Pro-Pro-Lys-Asp-NH2 | Antagonist | 98.14% | Unkown |
| HY-RS00166 | ACLY Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W024554 | AC-Asp(OtBU)-OH | 99.48% | Unkown | |
| HY-W048674 | Fmoc-Ser(Ac)-OH | 98.84% | Unkown | |
| HY-W114327 | N4-Acetyl-2'-O-methylcytidine | 98.0% | Unkown | |
| HY-16020 | AC-430 hydrobromide | Inhibitor | 99.70% | Unkown |
| HY-164054 | MicroRNA modulator-2 | Modulator | 99.54% | Unkown |
| HY-164582 | DMTr-2'-O-C22-rC(Ac)-3'-CE-Phosphoramidite | 98.0% | Unkown | |
| HY-177531 | S-Ac7-DOg | 99.69% | Unkown | |
| HY-W101366 | AC-PHE-OME | 99.87% | Unkown | |
| HY-103430 | SKF-83566 hydrobromide | Antagonist | / | Unkown |
| HY-112942 | CMP-Sialic acid | / | Unkown | |
| HY-115748A | Mant-GTPγS triammonium | Inhibitor | 93.30% | Unkown |
| HY-117867 | AVE-8063 | Inhibitor | 97.04% | Unkown |
| HY-118343 | AC-93253 | Inhibitor | 99.3% | Unkown |
| HY-125501 | Biotin-XX hydrazide | 99.01% | Unkown | |
| HY-134567A | Ac-VDVAD-CHO TFA | Inhibitor | 99.15% | Unkown |
| HY-138602 | 5'-O-DMT-N4-Ac-2'-F-dC | 99.11% | Unkown | |
| HY-138612 | 5'-O-DMT-3'-O-TBDMS-Ac-rC | 99.18% | Unkown | |
| HY-138614 | 5'-O-DMT-2'-O-TBDMS-Ac-rC | 99.80% | Unkown | |
| HY-141464 | Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH | 95.03% | Unkown | |
| HY-144287 | Glucokinase activator 3 | 98.36% | Unkown | |
| HY-147286A | Ac-Lys-Val-Cit-PABC-MMAE formic | 99.96% | Unkown | |
| HY-148043 | Schnurri-3 inhibitor-1 | Inhibitor | 99.07% | Unkown |
| HY-153613 | Ac-PLVE-FMK | Inhibitor | 98.0% | Unkown |
| HY-154592 | DMTr-TNA-G(O6-CONPh2)(N2Ac)-amidite | 98.38% | Unkown | |
| HY-158125 | PSMA binder-2 | 97.35% | Unkown | |
| HY-160109A | Ac5GalNTGc epimer | Inhibitor | 98.39% | Unkown |
| HY-168992 | UNC6535 | Inhibitor | / | Unkown |
| HY-180467 | Neu5Ac-2Galβ1-3Glc-oxazoline-(2)Me | / | Unkown | |
| HY-180467A | Neu5Ac-2Galβ1-3Glc-oxazoline-(2)Me sodium | / | Unkown | |
| HY-D1258 | AC-green | 98.04% | Unkown | |
| HY-N10772 | Albanin A | Inhibitor | 97.67% | Unkown |
| HY-P10142 | Ac-YEVD-AMC | 99.59% | Unkown | |
| HY-P10144 | Ac-Orn-Phe-Arg-AMC | / | Unkown | |
| HY-P10144A | Ac-Orn-Phe-Arg-AMC acetate | 99.45% | Unkown | |
| HY-P10145 | Ac-LEVD-pNA | 99.17% | Unkown | |
| HY-P10146 | Ac-LETD-CHO | Inhibitor | / | Unkown |
| HY-P10201 | Ac-GpYLPQTV-NH2 | Inhibitor | 99.38% | Unkown |
| HY-P10236 | Ac-WEHD-pNA | 99.46% | Unkown | |
| HY-P11326 | Ac-FR-AFC TFA | Substrate | 99.51% | Unkown |
| HY-P11392 | Ac-IEAR-pNA | Substrate | 99.82% | Unkown |
| HY-P11779 | Ac-RKAA-PABC-MMAE | Inhibitor | / | Unkown |
| HY-P11779A | Ac-RKAA-PABC-MMAE TFA | Inhibitor | / | Unkown |
| HY-P2632C | RAD16-I, free acid TFA | 98.11% | Unkown | |
| HY-P3362 | Ac-IETD-AMC | 98.50% | Unkown | |
| HY-P3364A | Ac-QPKK(Ac)-AMC acetate | Substrate | 99.38% | Unkown |
| HY-P3690 | Ac-Leu-Leu-Norleucinol | Inhibitor | / | Unkown |
| HY-P3761 | Ac-Tyr-Val-Lys-Asp-aldehyde | Inhibitor | 99.89% | Unkown |
| HY-P4449 | Ac-VRPR-AMC | / | Unkown | |
| HY-P4787A | Ac-Glu-Asp(EDANS)-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Gly-Lys(DABCYL)-Glu-NH2 acetate | Substrate | 99.44% | Unkown |
| HY-P5247A | Palmitoyl tetrapeptide-20 TFA | Activator | / | Unkown |
| HY-P6079A | Ac-IHIHIYI-NH2 TFA | 99.02% | Unkown | |
| HY-RS08844 | MUC5AC Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W013322 | Ac-Tyr-OEt.H2O | 98.57% | Unkown | |
| HY-W040802 | AC-94149 | 90.0% | Unkown | |
| HY-W096146 | Propynyl-PEG1-Ac | 95.0% | Unkown | |
| HY-W101384 | Ac-D-2-Nal-OH | 99.93% | Unkown | |
| HY-W1129940 | p-SCN-Macropa | / | Unkown | |
| HY-W145646 | Fmoc-L-Ser((Ac)4-β-D-Glc)-OH | ≥98.0% | Unkown | |
| HY-W214058 | Ac-2-Nal-OH | / | Unkown | |
| HY-W415798 | Ac4GalNAlk | 98.9% | Unkown | |
| HY-W570884 | 5-Me-dC(Ac) amidite | 97.0% | Unkown | |
| HY-Y1977A | 100 mM Pro-Ac, pH 5.0 buffer | 99.29% | Unkown | |
| HY-113402AR | Gamma-glutamylcysteine TFA (Standard) | / | Unkown | |
| HY-118806A | AC-42 hydrochloride | Agonist | 98.42% | Unkown |
| HY-121248 | Hydramethylnon | Inhibitor | 99.91% | Unkown |
| HY-13493 | AC710 | Inhibitor | 99.13% | Unkown |
| HY-154829A | AC-099 hydrochloride | Agonist | 99.92% | Unkown |
| HY-156287 | GCase modulator-1 | Modulator | 97.0% | Unkown |
| HY-163820 | WIZ degrader 4 | Degrader | 99.37% | Unkown |
| HY-164248 | Ac-rG | 99.69% | Unkown | |
| HY-171910 | tri(GalNAc-PEG2)-PEG4-cyclo(Ac-DCAW-{Arg(3F-Ph)-PEG2}-LGELVWCT) (Cys2-Cys12) | Ligand | 99.46% | Unkown |
| HY-185692 | Ac-Cys-Deruxtecan | / | Unkown | |
| HY-207857 | DMTr-Ac-5-Fluoro-2'-deoxycytidine-phosphoramidite | Substrate | / | Unkown |
| HY-N12920 | (Z)-3-Dodecenyl acetate | 98.0% | Unkown | |
| HY-W114328 | DMT-OMe-rC(Ac) | ≥97.0% | Unkown | |
| HY-W131753 | 2'-F-Ac-C | 99.64% | Unkown | |
| HY-W142294 | Ac-D-Asn-OH | / | Unkown | |
| HY-13001S | Quizartinib-d8 | / | Unkown | |
| HY-173135 | PROTAC KDM4 degrader-1 | / | Unkown | |
| HY-49538C | ASP7967 hemifumarate | Inducer | / | Unkown |
| HY-B0091S | Adapalene-d3 | / | Unkown | |
| HY-101863 | CB-6673567 | Inhibitor | / | Unkown |
| HY-103411 | SKF83822 hydrobromide | Agonist | / | Unkown |
| HY-106560 | Proglumetacin | Inhibitor | / | Unkown |
| HY-108487 | N-Acetyl-O-phosphono-Tyr-Glu dipentylamide | Inhibitor | / | Unkown |
| HY-108919 | CG-1521 | 95.71% | Unkown | |
| HY-113844A | Ac-Gly-Lys-OMe acetate | 98.91% | Unkown | |
| HY-115443 | MZH29 | Inhibitor | / | Unkown |
| HY-117118A | AC-90179 | Agonist | / | Unkown |
| HY-117616 | Laurotetanine | Inhibitor | / | Unkown |
| HY-117867A | AVE-8063 hydrochloride | / | Unkown | |
| HY-118464 | AC915 | / | Unkown | |
| HY-118806 | AC-42 | Agonist | / | Unkown |
| HY-120019A | Ac-YVAD-CHO acetate | Inhibitor | / | Unkown |
| HY-121738 | TC AC 28 | Inhibitor | / | Unkown |
| HY-125673 | AC-178335 | / | Unkown | |
| HY-126232 | Verproside | / | Unkown | |
| HY-128433 | CK1-IN-3 | Inhibitor | 99.00% | Unkown |
| HY-130629 | VHC-7 | Agonist | / | Unkown |
| HY-131805A | 3'-O-Ac-dGTP sodium | / | Unkown | |
| HY-134567 | Ac-VDVAD-CHO | Inhibitor | / | Unkown |
| HY-134684 | Mal-PEG3-O-Ac | / | Unkown | |
| HY-135020 | AC-24,055 | / | Unkown | |
| HY-135070B | Ac-RLR-AMC TFA | / | Unkown | |
| HY-135244 | Imazamethabenz-methyl | / | Unkown | |
| HY-135392S | N-Desmethyl Pimavanserin-d9 hydrochloride | / | Unkown | |
| HY-136112 | N-Succinimidyl acetate | 98.0% | Unkown | |
| HY-136727A | Ac-LEVD-CHO TFA | Inhibitor | / | Unkown |
| HY-136728 | Ac-YVAD-AOM | Inhibitor | / | Unkown |
| HY-136733 | Ac-DNLD-CHO | Inhibitor | / | Unkown |
| HY-136940 | Ac22(Az8)2 | Inhibitor | / | Unkown |
| HY-137527 | Ac-Lys(Ac)-D-Ala-D-Ala-OH | Activator | / | Unkown |
| HY-137744 | MANT-GppNHp | Inhibitor | / | Unkown |
| HY-137750 | MANT-cGMP | Inhibitor | / | Unkown |
| HY-138583 | Ac-dA Phosphoramidite | / | Unkown | |
| HY-138586S | DMT-dC(ac) Phosphoramidite-13C9, 15N3 | / | Unkown | |
| HY-141077 | N-(Ac-PEG3)-N'-(azide-PEG3)-Cy7 chloride | / | Unkown | |
| HY-141127 | Azido-PEG4-tetra-Ac-beta-D-glucose | / | Unkown | |
| HY-14277 | Levocabastine | Antagonist | / | Unkown |
| HY-143463 | AC-386 | Inhibitor | / | Unkown |
| HY-147397 | PKM2 activator 3 | Activator | / | Unkown |
| HY-148415 | Ac-Phe-Gly-pNA | / | Unkown | |
| HY-149552 | Ac4-5SGlcNAc | Inhibitor | / | Unkown |
| HY-150658S | DMT-2′O-TBDMS-rA(ac) phosphoramidite-15N | / | Unkown | |
| HY-150658S1 | DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C2 | / | Unkown | |
| HY-150658S2 | DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C3 | / | Unkown | |
| HY-150658S4 | DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C10 | / | Unkown | |
| HY-150658S5 | DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C10,15N5 | / | Unkown | |
| HY-150658S6 | DMT-2′O-TBDMS-rA(ac) phosphoramidite-15N5 | / | Unkown | |
| HY-150658S7 | DMT-2′O-TBDMS-rA(ac) phosphoramidite-d9 | / | Unkown | |
| HY-153614 | Ac-VLPE-FMK | Inhibitor | 99.0% | Unkown |
| HY-154213 | 5’-O-DMTr-5-MedC (Ac)-methyl phosphonamidite | / | Unkown | |
| HY-155229 | CBP/p300-IN-21 | Inhibitor | / | Unkown |
| HY-156020 | Glucocerebrosidase-IN-2 | Inhibitor | / | Unkown |
| HY-158119A | PSMA-trillium | Ligand | / | Unkown |
| HY-158776 | SLU-10482 | Inhibitor | / | Unkown |
| HY-159095 | PKR activator 5 | Activator | / | Unkown |
| HY-159593 | Ac-NH-(S,R,S)-AHPC-CO-cyclohexane-pyrimidine-diazabicyclo | / | Unkown | |
| HY-159601 | CSN5-IN-1 | Inhibitor | / | Unkown |
| HY-160536 | 2'-O-TOM-adenosine-(N-Ac)-3'-CEP | / | Unkown | |
| HY-160537 | 2'-O-TOM-guanosine-(N-Ac)-3'-CEP | / | Unkown | |
| HY-161160 | Ac4ManNDAz | / | Unkown | |
| HY-161519 | PKM2 activator 7 | Activator | / | Unkown |
| HY-162665 | WIZ degrader 1 | Inducer | / | Unkown |
| HY-162689 | GprA | Agonist | / | Unkown |
| HY-163818 | WIZ degrader 2 | Degrader | / | Unkown |
| HY-163819 | WIZ degrader 3 | Degrader | / | Unkown |
| HY-163951 | (S,R,S)-AHPC-Ac | / | Unkown | |
| HY-163952 | (S,R,S)-AHPC-Ac-CO-cyclohexene-Bpin | / | Unkown | |
| HY-168656 | Ac-Atovaquone | Inhibitor | / | Unkown |
| HY-169263 | AC10142A | Inhibitor | / | Unkown |
| HY-169824 | TRPML modulator 1 | Inducer | / | Unkown |
| HY-170841 | HDAC3/BRD4-IN-1 | Inhibitor | / | Unkown |
| HY-171279 | Casein kinase 1δ-IN-29 | / | Unkown | |
| HY-171489 | Mal-VC-PAB-EDA-N-Ac-Calicheamicin | / | Unkown | |
| HY-171960 | SHP2-IN-40 | Inhibitor | / | Unkown |
| HY-172914 | ACLY-IN-1 | Inhibitor | / | Unkown |
| HY-174151 | XSJ110 | / | Unkown | |
| HY-174968 | 4-Arm-PEG2000-AC | / | Unkown | |
| HY-174968A | 4-Arm-PEG5000-AC | / | Unkown | |
| HY-174968C | 4-Arm-PEG20000-AC | / | Unkown | |
| HY-175057 | Ac-IETD-CHO TFA | Inhibitor | / | Unkown |
| HY-175589 | XSJ81 | / | Unkown | |
| HY-175744 | PSMA-MAL-5 | Ligand | / | Unkown |
| HY-175755 | Ac-BIM-acid bromide | Inhibitor | / | Unkown |
| HY-176063 | TRPV1 antagonist 11 | / | Unkown | |
| HY-176804 | (R,S,R)-AHPC-Me-Ac | / | Unkown | |
| HY-177062 | NPRA agonist-11 | Agonist | / | Unkown |
| HY-177136 | ACLY-IN-2 | Inhibitor | / | Unkown |
| HY-178092 | Boc-(S)-Lys(Ac)-NH(4-CHO-Ph) | / | Unkown | |
| HY-178110 | HDAC6-IN-65 | / | Unkown | |
| HY-178336 | AC-340 | / | Unkown | |
| HY-178360 | NP1192 | / | Unkown | |
| HY-178429S | Acetyl-D-glutamine-d5 | / | Unkown | |
| HY-178485 | SJY26 | Inhibitor | / | Unkown |
| HY-179014 | OGG1 activator-1 | Activator | / | Unkown |
| HY-179173S | DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C | / | Unkown | |
| HY-179204 | 7-MAD-MDCPT-AC-(s-cyclopropane) | / | Unkown | |
| HY-179204S | 7-MAD-MDCPT-AC-(s-cyclopropane)-d2 | / | Unkown | |
| HY-179388 | PROTAC Sirt2 Degrader-2 | / | Unkown | |
| HY-180562 | KARS-IN-1 | Inhibitor | / | Unkown |
| HY-180795 | PKM2 activator 11 | / | Unkown | |
| HY-180889 | PROTAC BRD3 degrader-1 | Degrader | / | Unkown |
| HY-181024 | PROTAC HDAC8 Degrader-4 | Degrader | / | Unkown |
| HY-181058 | Cyclopamine-COO-2-ethoxy-1,3-benzodioxole-O-C-Triazole-C5-AC | / | Unkown | |
| HY-181669 | P300-IN-6 | Inhibitor | / | Unkown |
| HY-182002 | Apoptosis inducer 61 | / | Unkown | |
| HY-18234B | Leupeptin Ac-LL | Inhibitor | / | Unkown |
| HY-182750 | ACLY-IN-3 | Inhibitor | / | Unkown |
| HY-182751 | ACLY-IN-4 | Inhibitor | / | Unkown |
| HY-182837 | 8-Arm-PEG10000-Acrylate | / | Unkown | |
| HY-182837A | 8-Arm-PEG20000-Acrylate | / | Unkown | |
| HY-182837B | 8-Arm-PEG40000-Acrylate | / | Unkown | |
| HY-183249 | Ac-CoA Synthase-IN-2 | Inhibitor | / | Unkown |
| HY-183600 | SCN-PYTA | / | Unkown | |
| HY-183618 | DW-229 | Degrader | / | Unkown |
| HY-183975 | V-ATPase-IN-2 | Inhibitor | / | Unkown |
| HY-183992 | CZL-149 | Inhibitor | / | Unkown |
| HY-184270 | YM1240 | / | Unkown | |
| HY-184574 | HDAC-IN-104 | / | Unkown | |
| HY-185101 | MC-AcLys-GDEVD-PABC-Exatecan | / | Unkown | |
| HY-186220 | Macropa-4-(4-(3-butylthioureido)phenethoxy)picolinic | / | Unkown | |
| HY-187023 | Tubastatin A-C6-NHBoc | Degrader | / | Unkown |
| HY-402873 | DMTr-2'-O-C16-rC(Ac)-3'-CE-phosphoramidite | Inhibitor | / | Unkown |
| HY-48668 | AcLys-PABC-VC-Aur0101 intermediate-1 | / | Unkown | |
| HY-79490S | Ac-Exatecan-d5 | Inhibitor | 99.93% | Unkown |
| HY-CE01449 | Ac-Lys(CoA)-NH2 | / | Unkown | |
| HY-D2379A | closed-HMRG | / | Unkown | |
| HY-D2974 | DCI-Ac-HMPC | / | Unkown | |
| HY-D2982 | BTP9-Neu5Ac | / | Unkown | |
| HY-D2989 | BG-NH2-Ac-N3 | / | Unkown | |
| HY-E70019 | alpha-2-3,6-sialidase (BiNanH2) | / | Unkown | |
| HY-E70621 | Sialic acid aldolase (Pm NaNa) | / | Unkown | |
| HY-N11726 | Ageconyflavone B | Modulator | / | Unkown |
| HY-N15826 | RBM1-151 | Substrate | / | Unkown |
| HY-N18053 | Anabsinthin | / | Unkown | |
| HY-N7872 | Ac-wilforsinine N | / | Unkown | |
| HY-N8356 | 13-cis-Vitamin A palmitate | / | Unkown | |
| HY-N8356A | 9-cis-Vitamin A palmitate | / | Unkown | |
| HY-NP012B | Acetylated low density lipoprotein, human | / | Unkown | |
| HY-NP012C | Dil acetylated low density lipoprotein, human | / | Unkown | |
| HY-P0211 | [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) | Antagonist | / | Unkown |
| HY-P1001A | Ac-DEVD-CHO TFA | / | Unkown | |
| HY-P10070 | Ac-pSar16-OH | / | Unkown | |
| HY-P10082 | Ac-VETD-AMC | / | Unkown | |
| HY-P10083 | Ac-VQVD-pNA | / | Unkown | |
| HY-P10084 | Ac-VAD-pNA | / | Unkown | |
| HY-P10147 | Ac-LDESD-AMC | Inhibitor | / | Unkown |
| HY-P10161 | Ac-DMQD-pNA | / | Unkown | |
| HY-P10162 | Ac-DMQD-AMC | / | Unkown | |
| HY-P10162A | Ac-DMQD-AMC TFA | / | Unkown | |
| HY-P10175 | Acetalin-1 | Antagonist | / | Unkown |
| HY-P10176 | Acetalin-2 | / | Unkown | |
| HY-P10177 | Acetalin-3 | Antagonist | / | Unkown |
| HY-P10215 | Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2 | Inhibitor | / | Unkown |
| HY-P10231 | Ac-Phe-Thiaphe-OH | / | Unkown | |
| HY-P10240 | Ac-WVAD-AMC | / | Unkown | |
| HY-P10241 | Ac-LEHD-CHO | Inhibitor | / | Unkown |
| HY-P10243 | Ac-VAD-CMK | Inhibitor | / | Unkown |
| HY-P10244 | Ac-YVAD-FMK | Inhibitor | / | Unkown |
| HY-P10276 | Ac-VAD-AFC | / | Unkown | |
| HY-P10452 | Ac-LEVDGWK(Dnp)-NH2 | / | Unkown | |
| HY-P10656 | Ac-DEVDD-TPP | Inducer | / | Unkown |
| HY-P10667 | Ac-MRGDH-NH2 | / | Unkown | |
| HY-P10706 | Ac-ILVAGK-NH2 | / | Unkown | |
| HY-P10939 | Ac-DMLD-CMK | Inhibitor | / | Unkown |
| HY-P10955 | Ac-AAVALLPAVLLALLAPVAD-CHO TFA | Inhibitor | / | Unkown |
| HY-P11154 | HAV peptide | Modulator | / | Unkown |
| HY-P1118A | Ac9-25 TFA | / | Unkown | |
| HY-P11198 | AC-P19M | / | Unkown | |
| HY-P11287 | DOTA-Pep-1L | Ligand | / | Unkown |
| HY-P11297 | AC-SDKP-NH2 | / | Unkown | |
| HY-P11325 | Ac-RR-AFC TFA | Substrate | 99.56% | Unkown |
| HY-P11406 | Ac-RSLK-AMC | / | Unkown | |
| HY-P11416 | Ac-RGDS-NH2 | Antagonist | / | Unkown |
| HY-P11420 | 2A/2B Dengue protease substrate | / | Unkown | |
| HY-P11427 | Ac-LVSR-AMC | / | Unkown | |
| HY-P11491 | Ac2-26 (mouse) | Inhibitor | / | Unkown |
| HY-P1169A | Ac-IETD-AFC TFA | / | Unkown | |
| HY-P11842 | Ac-HFKLYWPPFLGS-NH2 | Inhibitor | / | Unkown |
| HY-P11865 | Ac-ATS010-KE | Inhibitor | / | Unkown |
| HY-P1200 | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH | Inhibitor | / | Unkown |
| HY-P1200A | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH TFA | Inhibitor | / | Unkown |
| HY-P1316 | Ac-RYYRWK-NH2 | Antagonist | / | Unkown |
| HY-P1316A | Ac-RYYRWK-NH2 TFA | Agonist | / | Unkown |
| HY-P1318 | Ac-RYYRIK-NH2 | Agonist | / | Unkown |
| HY-P1318A | Ac-RYYRIK-NH2 TFA | Agonist | / | Unkown |
| HY-P1734 | Ac-MBP (1-11) | / | Unkown | |
| HY-P2374 | Ac-DMQD-CHO | Inhibitor | / | Unkown |
| HY-P2413 | Ac-PPPHPHARIK-NH2 | Inhibitor | / | Unkown |
| HY-P2610 | Ac-VEID-pNA | Activator | / | Unkown |
| HY-P2615 | Ac-VDVAD-AFC | / | Unkown | |
| HY-P2617 | Ac-WEHD-AFC | / | Unkown | |
| HY-P2633A | Dentonin TFA | / | Unkown | |
| HY-P2977 | N-Acetylneuraminate lyase (CgNal) | / | Unkown | |
| HY-P3110 | Ac-DNLD-AMC | / | Unkown | |
| HY-P3307 | Ac-Val-Gln-aIle-Val-aTyr-Lys-NH2 | / | Unkown | |
| HY-P3364 | Ac-QPKK(Ac)-AMC | Substrate | / | Unkown |
| HY-P3434 | Ac-FEID-CMK | Inhibitor | / | Unkown |
| HY-P3729 | Ac-Lys-D-Ala-D-Ala-OH | / | Unkown | |
| HY-P3940 | Ac-MBP (4-14) Peptide | / | Unkown | |
| HY-P4019 | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | / | Unkown | |
| HY-P4039 | Ac-EEVVAC-pNA | / | Unkown | |
| HY-P4040 | Ac-D-DGla-LI-Cha-C | Inhibitor | / | Unkown |
| HY-P4408 | Ac-Arg-Gly-Lys-AMC | / | Unkown | |
| HY-P4416 | Ac-Gly-Ala-Lys(Ac)-AMC | / | Unkown | |
| HY-P4443 | Ac-GAK-AMC | / | Unkown | |
| HY-P4448 | Ac-Gly-Pro-AFC | / | Unkown | |
| HY-P4519 | Ac-Lys(Ac)-D-Ala-D-Lactic acid | Substrate | / | Unkown |
| HY-P4532 | Ac-Leu-Val-Lys-Aldehyde | Inhibitor | / | Unkown |
| HY-P4535 | Ac-Trp-Glu-His-Asp-Aldehyde | Inhibitor | / | Unkown |
| HY-P4688 | (Ser(Ac)4,D-Ser(tBu)6,Azagly10)-LHRH | / | Unkown | |
| HY-P4787 | Ac-Glu-Asp(EDANS)-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Gly-Lys(DABCYL)-Glu-NH2 | / | Unkown | |
| HY-P4832 | Acetyl-Tau Peptide (273-284) amide | Inhibitor | / | Unkown |
| HY-P5045 | Fmoc-Thr(GalNAc(Ac)3-β-D)-OH | / | Unkown | |
| HY-P5280 | Ac-KQL-AMC | / | Unkown | |
| HY-P5378 | Ac-KQKLR-AMC | / | Unkown | |
| HY-P5525 | AC3-I, myristoylated | Inhibitor | / | Unkown |
| HY-P5830A | Biotin-DEVD-CHO TFA | Inhibitor | / | Unkown |
| HY-P5922 | PTD2 | Inhibitor | / | Unkown |
| HY-P5936 | Ac-AAVALLPAVLLALLAP-DEVD-CHO | Inhibitor | / | Unkown |
| HY-P5938 | Ac-AAVALLPAVLLALLAP-YVAD-CHO | Inhibitor | / | Unkown |
| HY-P5955 | Ac-AAVALLPAVLLALLAP-LEVD-CHO | Inhibitor | / | Unkown |
| HY-P5956 | Ac-AAVALLPAVLLALLAP-LEHD-CHO | Inhibitor | / | Unkown |
| HY-P6079 | Ac-IHIHIYI-NH2 | / | Unkown | |
| HY-R01635 | hsa-miR-548ac mimic | / | Unkown | |
| HY-R01635A | hsa-miR-548ac agomir | / | Unkown | |
| HY-RI01635 | hsa-miR-548ac inhibitor | / | Unkown | |
| HY-RI01635A | hsa-miR-548ac antagomir | / | Unkown | |
| HY-RS00167 | Acly Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS00168 | Acly Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05088 | FRA10AC1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05955 | H2AC18 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W004066S | Ac-Ala-OH-d3 | 99.0% | Unkown | |
| HY-W004066S1 | Ac-Ala-OH-d4 | / | Unkown | |
| HY-W009929 | AC-45594 | 99.94% | Unkown | |
| HY-W010389S2 | Ac-DL-Ala-OH-d4 | / | Unkown | |
| HY-W011254 | Ac-VAD-CHO | Inhibitor | / | Unkown |
| HY-W012713S | Ac-D-Ala-OH-d4 | 99.0% | Unkown | |
| HY-W012713S1 | Ac-D-Ala-OH-d3 | / | Unkown | |
| HY-W014130A | N-Acetyl-L-arginine dihydrate | / | Unkown | |
| HY-W015241 | Ac-D-Glu-OH | / | Unkown | |
| HY-W015241S | Ac-D-Glu-OH-d5 | 99.0% | Unkown | |
| HY-W016584 | 4,5-Dichlorocatechol | Inhibitor | / | Unkown |
| HY-W042357S | Ac-rC Phosphoramidite-15N | / | Unkown | |
| HY-W042357S1 | Ac-rC Phosphoramidite-15N2 | / | Unkown | |
| HY-W042357S2 | Ac-rC Phosphoramidite-15N3 | / | Unkown | |
| HY-W042357S3 | Ac-rC Phosphoramidite-13C2,d1 | / | Unkown | |
| HY-W042357S4 | Ac-rC Phosphoramidite-13C9 | / | Unkown | |
| HY-W042357S5 | Ac-rC Phosphoramidite-13C,d1 | / | Unkown | |
| HY-W042357S6 | Ac-rC Phosphoramidite-13C9,15N3 | / | Unkown | |
| HY-W044285 | Fmoc-D-4-Aph(cBm)-OH | / | Unkown | |
| HY-W145531 | Neu5GcAc[1Me,478Ac,9N3]-β-SPh | / | Unkown | |
| HY-W145540 | Galβ(1-3)[Neu5Acα(2-6)]GalNAc-α-pNP | / | Unkown | |
| HY-W145548 | GlcNPhth[36Bn,4Ac]-β-MP | / | Unkown | |
| HY-W145609 | Neu5Troc[1Me,4789Ac]α(2-3)Gal[26Bn]-β-MP | / | Unkown | |
| HY-W145622 | Galβ(1-3)[Neu5Acα(2-6)]GlcNAc-β-pNP | / | Unkown | |
| HY-W393498 | Phenyl 2,4,6-tri-O-acetyl-3-O-allyl-β-D-thiogalactopyranoside | / | Unkown | |
| HY-W560922 | Piperazine-Ac-OMe | / | Unkown | |
| HY-W560961 | 3',5'-TIPS-N-Ac-Adenosine | / | Unkown | |
| HY-W713878 | Ac-VDVAD-pNA | / | Unkown | |
| HY-W752012 | Adapalene-13C6 | / | Unkown | |
| HY-W766388 | 2-Amino-2-deoxyglucose hydrochloride-13C6 | / | Unkown | |
| HY-W768178 | 2-Amino-2-deoxyglucose hydrochloride-13C2 | / | Unkown | |
| HY-W783407S | Ac-rG Phosporamidite-15N | / | Unkown | |
| HY-W783407S1 | Ac-rG Phosporamidite-13C | / | Unkown | |
| HY-W783407S2 | Ac-rG Phosporamidite-13C2 | / | Unkown | |
| HY-W783407S3 | Ac-rG Phosporamidite-13C10 | / | Unkown | |
| HY-W783407S4 | Ac-rG Phosporamidite-13C10,15N5 | / | Unkown | |
| HY-W783407S5 | Ac-rG Phosporamidite-15N5 | / | Unkown | |
| HY-W783407S6 | Ac-rG Phosporamidite-d9 | / | Unkown | |
| HY-W854187 | 2'-Ome-Ac-G Phosporamidite | / | Unkown | |
| HY-104004R | Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH (Standard) | / | Unkown | |
| HY-104032R | Ac-CoA Synthase-IN-1 (Standard) | Inhibitor | / | Unkown |
| HY-106530 | Gitoformate | / | Unkown | |
| HY-10658 | AC-7954 | / | Unkown | |
| HY-108312 | Ac-VEID-CHO | Inhibitor | / | Unkown |
| HY-110209 | AC4 | Antagonist | / | Unkown |
| HY-112942B | CMP-Sialic acid disodium | / | Unkown | |
| HY-113402B | Gamma-glutamylcysteine ammonium | / | Unkown | |
| HY-113844 | Ac-Gly-Lys-OMe | / | Unkown | |
| HY-120278 | 4-Ethoxyquinazoline | / | Unkown | |
| HY-129027 | Ac-Leu-Gly-Lys(Ac)MCA | / | Unkown | |
| HY-129648 | AC-7954 free base | / | Unkown | |
| HY-131804A | 3'-O-Acetyl-2'-deoxycytidine-5'-O-triphosphate tetrasodium | / | Unkown | |
| HY-131806A | 3'-O-Ac-dTTP sodium | / | Unkown | |
| HY-134373A | Bis-Cl-ANT-ATP tetrasodium | Inhibitor | / | Unkown |
| HY-13493A | AC710 Mesylate | Inhibitor | / | Unkown |
| HY-138165 | Ac-Phe-NH2 | 98.41% | Unkown | |
| HY-148313 | PKM2 activator 4 | Activator | / | Unkown |
| HY-154036 | 5′-DMTr-dC (Ac)-Methylphosphonamidite | / | Unkown | |
| HY-154829 | AC-099 | Agonist | / | Unkown |
| HY-157171 | Ac-YR-NH2 | Modulator | / | Unkown |
| HY-157232 | AC Antibody purification resin 2 | / | Unkown | |
| HY-157233 | AC Antibody purification resin 1 | / | Unkown | |
| HY-157235 | AC Antibody affinity resin | / | Unkown | |
| HY-158792 | GK241 | / | Unkown | |
| HY-160535 | 2'-O-TOM-Cytidine-(N-Ac)-3'-CEP | / | Unkown | |
| HY-161021 | AC2 selective-IN-1 | / | Unkown | |
| HY-161913 | AC-4-248 | Inhibitor | / | Unkown |
| HY-162159 | Ac-Cys-NHMe | / | Unkown | |
| HY-163106 | W000113414_I13 | Agonist | / | Unkown |
| HY-164053 | miR-21-IN-3 | Inhibitor | 99.58% | Unkown |
| HY-164249 | DMT-rG(Ac) | / | Unkown | |
| HY-164253 | TBS-rG(Ac) | / | Unkown | |
| HY-171289 | Neu5Acα2-6GalNAcα1-4GlcNac | / | Unkown | |
| HY-171463 | AC-271337 | / | Unkown | |
| HY-177738 | 6'Nicotinate Ac4ManNAz | / | Unkown | |
| HY-178523 | 6'-O-DMTr-2'-O-Me-5'-Homo-C(Ac)-3'-CE-phosphoramidite | / | Unkown | |
| HY-178562 | DMTr-2'-O-propargyl-rC(Ac)-3' -CE-Phosphoramidite | / | Unkown | |
| HY-178569 | DMTr-S-5-C-Me-2'-O-Me-rC(Ac)-3'-CE-phosphoramidite | / | Unkown | |
| HY-178604 | DMTr-2'-O-Bn-rC(Ac)-3'-CE-phosphoramidite | / | Unkown | |
| HY-178610 | 2',3'-Dideoxy-C(Ac) | / | Unkown | |
| HY-178616 | 5'-O-DMTr-2'-O-(2-cyanoethoxymethyl)-rC(Ac) | / | Unkown | |
| HY-178617 | 5'-O-DMTr-2'-O-(2-cyanoethoxymethyl)-rA(Ac) | / | Unkown | |
| HY-178627 | 5'-O-DMTr-2'-O-TOM-rA(Ac) | / | Unkown | |
| HY-178641 | 4'-O-Ac-3'-O-Bz-2'-O-Me-N3-Bz-U | / | Unkown | |
| HY-178666 | 2'-O-Propargyl-rC(Ac) | / | Unkown | |
| HY-178668 | 2'-O-MOE-rC(Ac) | / | Unkown | |
| HY-180519 | Ac-N-m-(CF3)2-Ph-C-Py | / | Unkown | |
| HY-180796 | PKM2 agonist-1 | Agonist | / | Unkown |
| HY-181784 | Ac-CoA-IN-1 | Inhibitor | / | Unkown |
| HY-182170 | N4-Ac-N4-Et-dC-CE phosphoramidite | / | Unkown | |
| HY-184367 | Ac-L-Asp-pNA | / | Unkown | |
| HY-184421 | Antibacterial agent 354 | Inhibitor | / | Unkown |
| HY-19647 | Ritipenem acoxil | Inhibitor | / | Unkown |
| HY-202974 | 5-Me-DMT-2'-O-MOE-C(Ac)-CE-phosphoramidite | / | Unkown | |
| HY-20560 | (Ac)Phe-Lys(Alloc)-PABC-PNP | / | Unkown | |
| HY-43565C | (1S,9R)-Ac-Exatecan | / | Unkown | |
| HY-N10628 | Neu5Acα(2-6) N-Glycan | / | Unkown | |
| HY-N12336 | Gnetuhainin I | / | Unkown | |
| HY-N12894 | (Z,E)-7,11-Hexadecadienyl acetate | / | Unkown | |
| HY-P10639A | C5aR2 agonist P32 acetate | Agonist | / | Unkown |
| HY-P10657 | Ac-DEMEEC-OH | Inhibitor | / | Unkown |
| HY-P10666 | Ac-VDQQD-pNA | / | Unkown | |
| HY-P10668 | Ac-EVKKQR-pNA | Inhibitor | / | Unkown |
| HY-P2620 | Ac-LETD-AFC | / | Unkown | |
| HY-P3234 | Ac-ESMD-CHO | Inhibitor | / | Unkown |
| HY-RS17212 | Muc5ac Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23664 | Muc5ac Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W042357 | Ac-rC Phosphoramidite | 98.87% | Unkown | |
| HY-W1121775 | DMT-2'O-TC-rC(ac) phosphoramidite | / | Unkown | |
| HY-W1121781 | 2'-OMe-C(Ac)-3'-methoxy phosphoramidite | / | Unkown | |
| HY-W129441 | N-Acetyl-4-S-cysteaminylphenol | / | Unkown | |
| HY-W129617 | 3',5'-TIPS-N-Ac-cytidine | 95.0% | Unkown | |
| HY-W130878 | 4-Octylphenol | Activator | / | Unkown |
| HY-W293394 | Boc-cyclohexane-piperazine-Ac-Ph | / | Unkown | |
| HY-W338079 | Ac-Asp-Glu-Val-Asp-pNA | Substrate | / | Unkown |
| HY-W415799 | (2S)-Ac4GalNAl | / | Unkown | |
| HY-W780787 | (E,Z)-3,13-Octadecadienyl acetate | / | Unkown | |
| HY-W783407 | Ac-rG Phosporamidite | / | Unkown | |
| HY-W881463 | N4-Ac-C-(S)-GNA phosphoramidite | / | Unkown |
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99715 | Losatuxizumab | Inhibitor | 99.44% | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Felis catus | ACLY | VGNC | VGNC:59513 |
| Canis familiaris | ACLY | VGNC | VGNC:37511 |
| Macaca mulatta | ACLY | VGNC | VGNC:99112 |
| Rattus norvegicus | ACLY | RGD | RGD:2018 |
| Bos taurus | ACLY | VGNC | VGNC:25543 |
| Mus musculus | ACLY | MGD | MGI:103251 |
| Others | ACLY | NCBI |